Invest now
Poly Medicure share price
High risk
You have to be logged in to add this to Watchlist.- ₹1,697.00(-0.69%)August 7, 2026 15:28:59 PM IST
- NSE
- BSE
- Vol : 231.53 K (NSE + BSE)Last 20 day avg : 94.13 K
Poly Medicure is trading -0.69% lower at Rs 1,697.00 as compared to its last closing price. Poly Medicure has been trading in the price range of 1,744.65 & 1,661.85. Poly Medicure has given -3.63% in this year & 2.53% in the last 5 days. There are 5 analysts who have initiated coverage on Poly Medicure. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 66.29 Crores in its last quarter.Listed peers of Poly Medicure include Lenskart Solutions (0.69%), Laxmi Dental (-0.48%), Mallcom (India) (-1.49%).The Mutual Fund holding in Poly Medicure was at 9.61% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Poly Medicure was at 5.56% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 09 Aug 2026, 03:33 PM IST
- BetaMedium volatility0.92Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Dividend YieldLower than industry0.20Annual dividends as a percentage of the stock price.
- P/BLower than historical values5.58The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values53.84Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation2.78The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Poly Medicure News
Poly Medicure Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Lenskart Solutions | 568.90 | 0.69 | 98,793.41 | 181.00 | 10.67 | - | 26.70 |
| Laxmi Dental | 217.40 | -0.48 | 1,204.53 | 35.63 | 5 | - | 3.73 |
| Mallcom (India) | 1,000.00 | -1.49 | 623.11 | 21.91 | 2.07 | 0.28 | 1.96 |
| One Global Service Provider | 568.80 | 0.32 | 1,111.61 | 16.95 | 8.34 | - | 0.02 |
| Hemant Surgical Industries | 362.00 | 0.63 | 518.69 | 26.04 | 3.68 | - | 2.09 |
Mutual Fund Ownership
View allPoly Medicure Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-25 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-08-08 | Quarterly Results & Others |
About the company Poly Medicure
- IndustryMedical Equipment & Supplies
- ISININE205C01021
- BSE Code531768
- NSE CodePOLYMED
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.
Poly Medicure Share Price FAQs
Poly Medicure is trading at 1697.00 as on Fri Aug 07 2026 09:58:59. This is -0.69% lower as compared to its previous closing price of 1708.85.
The market capitalization of Poly Medicure is 17249.67 Cr as on Fri Aug 07 2026 09:58:59.
The average broker rating on Poly Medicure is Hold. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 2 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Poly Medicure is 2143.60 whereas the 52 wk low is 1184.00
Poly Medicure can be analyzed on the following key metrics -
- TTM P/E: 37.47
- Sector P/E: -
- Dividend Yield: 0.20%
- D/E ratio: 0.11
Poly Medicure reported a net profit of 322.14 Cr in 2026.
The Mutual Fund Shareholding was 9.61% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Poly Medicure QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.